Alembic Pharmaceuticals Ltd

Held by 48 funds in our universe · avg weight 0.56% · range 0.00% to 3.18%

Fundamentals

Current price ₹760.1

Market cap ₹15,577 cr

P/E (TTM) 22.5

P/B 2.7

ROE 11.9%

Debt / equity 25.22

Revenue growth +25.7%

Profit margin 8.9%

Dividend yield 1.50%

P/E history band: 26-31 · currently cheap vs own history

Technicals · split/bonus-adjusted

From 52-wk high -20.9%

52-week high ₹960.7

52-week low ₹646.5

200-day MA ₹779.2

vs 200D MA -2.5%

Worst drop 3y -48.2%

Worst drop all-time -58.4%

Market-cap class Small Cap

Price as of 2026-10-23

Funds by category

All (48) Other – Index Funds (10) Equity – Sectoral/ Thematic (7) Equity – Small Cap Fund (5) Other – Other ETFs (4) Solution Oriented – Retirement Fund (3) Equity – Mid Cap Fund (2) Hybrid – Multi Asset Allocation (2) Equity – ELSS (2) Equity – Value Fund (2) Hybrid – Aggressive Hybrid Fund (2) Equity – Flexi Cap Fund (2) Equity – Large & Mid Cap Fund (1) Solution Oriented – Children’s Fund (1) Equity – Large Cap Fund (1) Equity – Multi Cap Fund (1) Hybrid – Equity Savings (1) Other – FoF Domestic (1) Hybrid – Conservative Hybrid Fund (1)

Showing only Hybrid – Multi Asset Allocation funds. clear filter

2 Hybrid – Multi Asset Allocation funds holding this stock , sorted by the stock's weight in each fund

Fund	Category	% of fund in this stock	As of
The Wealth Company Multi Asset Allocation Fund - Direct Plan - Growth The Wealth Company Mutual Fund	Hybrid · Multi Asset Allocation	1.05%	2026-09-30
DSP Multi Asset Allocation Fund - Direct Plan - Growth DSP Mutual Fund	Hybrid · Multi Asset Allocation	0.08%	2026-05-31

Holdings sourced from scheme portfolios as published by their AMCs each month under SEBI rules. "% of fund in this stock" is the position weight inside each fund, NOT the rupee value of any individual investor's exposure.